Integral Diagnostics Ltd (ASX:IDX)
A$ 2.92 0.05 (1.74%) Market Cap: 1.07 Bil Enterprise Value: 1.38 Bil PE Ratio: 0 PB Ratio: 2.22 GF Score: 85/100

Full Year 2020 Integral Diagnostics Ltd Earnings Call Transcript

Aug 25, 2020 / 12:30AM GMT
Release Date Price: A$4.02 (+4.08%)
Operator

Thank you for standing by, and welcome to Integral Diagnostics Limited, IDX, Full Year 2020 Results Conference Call. (Operator Instructions)

I would now like to turn the call over to Dr. Ian Kadish, Managing Director and CEO. Thank you. You may begin.

Ian Kadish
Integral Diagnostics Limited - CEO, MD & Director

Thank you very much. Good morning. It's great to be here and to be able to share a really strong set of results for what has been a challenging year. My name is Ian Kadish, I'm the Chief Executive and Managing Director of Integral Diagnostics. I'm joined here this morning by Anne Lockwood, our Chief Financial and Commercial Officer. And it's our privilege this morning to be able to share with you a really solid set of results for financial year '20.

Integral Diagnostics, as most of you know, is a diagnostic imaging company. We do x-rays and ultrasounds and CT, MRIs and nuclear medicine studies on patients that are referred to us by doctors, GPs and specialists and by other referrers across Australia and New Zealand.

Our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot